267 related articles for article (PubMed ID: 24578660)
1. Duration of antimicrobial therapy in community acquired pneumonia: less is more.
Pinzone MR; Cacopardo B; Abbo L; Nunnari G
ScientificWorldJournal; 2014; 2014():759138. PubMed ID: 24578660
[TBL] [Abstract][Full Text] [Related]
2. How to reduce antibiotic consumption for community-acquired pneumonia?
Montassier E; Goffinet N; Potel G; Batard E
Med Mal Infect; 2013 Feb; 43(2):52-9. PubMed ID: 23433607
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin and community-acquired pneumonia (CAP) in children.
Giulia B; Luisa A; Concetta S; Bruna LS; Chiara B; Marcello C
Clin Chim Acta; 2015 Dec; 451(Pt B):215-8. PubMed ID: 26434548
[TBL] [Abstract][Full Text] [Related]
4. Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients.
López-Alcalde J; Rodriguez-Barrientos R; Redondo-Sánchez J; Muñoz-Gutiérrez J; Molero García JM; Rodríguez-Fernández C; Heras-Mosteiro J; Marin-Cañada J; Casanova-Colominas J; Azcoaga-Lorenzo A; Hernandez Santiago V; Gómez-García M
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD009070. PubMed ID: 30188565
[TBL] [Abstract][Full Text] [Related]
5. Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP).
Deshpande A; Walker R; Schulte R; Pallotta AM; Tereshchenko LG; Hu B; Kadri SS; Klompas M; Rothberg MB
Trials; 2023 Sep; 24(1):595. PubMed ID: 37716990
[TBL] [Abstract][Full Text] [Related]
6. A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia.
Foolad F; Huang AM; Nguyen CT; Colyer L; Lim M; Grieger J; Li J; Revolinski S; Mack M; Gandhi T; Wainaina JN; Eschenauer G; Patel TS; Marshall VD; Nagel J
J Antimicrob Chemother; 2018 May; 73(5):1402-1407. PubMed ID: 29462306
[TBL] [Abstract][Full Text] [Related]
7. Short-course vs long-course antibiotic treatment for community-acquired pneumonia: A literature review.
Møller Gundersen K; Nygaard Jensen J; Bjerrum L; Hansen MP
Basic Clin Pharmacol Toxicol; 2019 May; 124(5):550-559. PubMed ID: 30694600
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic stewardship in community-acquired pneumonia.
Viasus D; Vecino-Moreno M; De La Hoz JM; Carratalà J
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):351-359. PubMed ID: 28002979
[TBL] [Abstract][Full Text] [Related]
9. Outpatient Antimicrobial Stewardship: Targets for Community-acquired Pneumonia.
Wattengel BA; Sellick JA; Skelly MK; Napierala R; Schroeck J; Mergenhagen KA
Clin Ther; 2019 Mar; 41(3):466-476. PubMed ID: 30739721
[TBL] [Abstract][Full Text] [Related]
10. Short-course antimicrobial therapy for community-acquired pneumonia.
Kolditz M; Halank M; Höffken G
Treat Respir Med; 2005; 4(4):231-9. PubMed ID: 16086597
[TBL] [Abstract][Full Text] [Related]
11. Duration of pneumonia therapy and the role of biomarkers.
Kaziani K; Sotiriou A; Dimopoulos G
Curr Opin Infect Dis; 2017 Apr; 30(2):221-225. PubMed ID: 28079629
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis.
Kamat IS; Ramachandran V; Eswaran H; Guffey D; Musher DM
Clin Infect Dis; 2020 Jan; 70(3):538-542. PubMed ID: 31241140
[TBL] [Abstract][Full Text] [Related]
13. Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis.
Dimopoulos G; Matthaiou DK; Karageorgopoulos DE; Grammatikos AP; Athanassa Z; Falagas ME
Drugs; 2008; 68(13):1841-54. PubMed ID: 18729535
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.
Christ-Crain M; Stolz D; Bingisser R; Müller C; Miedinger D; Huber PR; Zimmerli W; Harbarth S; Tamm M; Müller B
Am J Respir Crit Care Med; 2006 Jul; 174(1):84-93. PubMed ID: 16603606
[TBL] [Abstract][Full Text] [Related]
15. What is the role of antimicrobial stewardship in improving outcomes of patients with CAP?
Nussenblatt V; Avdic E; Cosgrove S
Infect Dis Clin North Am; 2013 Mar; 27(1):211-28. PubMed ID: 23398876
[TBL] [Abstract][Full Text] [Related]
16. [Short course antibiotic treatment during community acquired pneumonia: Review of the literature and perspectives].
Philippot Q; Dinh A; Voiriot G
Rev Mal Respir; 2020 Jan; 37(1):26-33. PubMed ID: 31883818
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia.
Long W; Deng X; Zhang Y; Lu G; Xie J; Tang J
Respirology; 2011 Jul; 16(5):819-24. PubMed ID: 21507143
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis.
Li JZ; Winston LG; Moore DH; Bent S
Am J Med; 2007 Sep; 120(9):783-90. PubMed ID: 17765048
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the impact of clinical recommendations on antibiotic use for CAP and HCAP: results from an implementation program in an Academic Hospital.
Cattani G; Madia A; Arnoldo L; Brunelli L; Celotto D; Grillone L; Valent F; Castriotta L; Pea F; Bassetti M; Brusaferro S
Ann Ig; 2020; 32(4):344-356. PubMed ID: 32744293
[TBL] [Abstract][Full Text] [Related]
20. A CAP on antibiotic duration.
Wunderink RG
Am J Respir Crit Care Med; 2006 Jul; 174(1):3-5. PubMed ID: 16793998
[No Abstract] [Full Text] [Related]
[Next] [New Search]
